I consent to receive newsletters via email. Terms of use and Privacy policy.

In partnership with


Good Morning! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City.

Hit the Gong 🎉

My Favorite Newsletter: Stay ahead on the business of AI 

Have you heard of Prompts Daily newsletter? I recently came across it and absolutely love it.

AI news, insights, tools and workflows. If you want to keep up with the business of AI, you need to be subscribed to the newsletter (it’s free).

Read by executives from industry-leading companies like Google, Hubspot, Meta, and more.

Want to receive daily intel on the latest in business/AI?

Daily Deals 💸

🌎 Americas

AltruBio has developed an antibody therapeutics platform that focuses on the discovery and development of novel therapeutics for unmet medical needs in the field of antibody-drug conjugates therapy, enabling patients to recover from immune-mediated diseases. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $225M, Series B

Round Investors: Biotechnology Value Fund (lead), Soleus Capital, RA Capital Management, aMoon Fund

🚀Growth Focus: Advance its ulcerative colitis candidate into mid-stage clinical trials.

HQ: San Francisco, CA

Industry: Biotechnology Research

Employee Count: 31

Farcaster operates a decentralized social network with an open protocol that can support many clients and secure their social data, enabling users to own and control their social graph. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $150M, Series A

Round Investors: Paradigm (lead), Union Square Ventures, Haun Ventures, Standard Crypto

🚀Growth Focus: Expand its decentralized social networking features such as channels and direct messaging.

HQ: Los Angeles, CA

Industry: Internet Publishing

Employee Count: 12 (⚡140% increase in last 6 months)

Upgrade Now

Get access to premium content

Subscribe